Related references
Note: Only part of the references are listed.Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non-Small-Cell Lung Cancer Implications for Therapy
Martin K. H. Maus et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
ERCC1 Isoform Expression and DNA Repair in Non-Small-Cell Lung Cancer
Luc Friboulet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Douglas G. Altman et al.
BMC MEDICINE (2012)
Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer
Jin-Soo Kim et al.
CANCER (2012)
Expression of Tumor-Derived Vascular Endothelial Growth Factor and Its Receptors Is Associated With Outcome in Early Squamous Cell Carcinoma of the Lung
Maria J. Pajares et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells
Gengyun Wen et al.
CANCER LETTERS (2011)
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells
Miranda P. Ween et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Alex Chang
LUNG CANCER (2011)
Five-Year Lung Cancer Survival - Which Advanced Stage Nonsmall Cell Lung Cancer Patients Attain Long-Term Survival?
Tina Wang et al.
CANCER (2010)
The Evolving Role of Histology in the Management of Advanced Non-Small-Cell Lung Cancer
Corey J. Langer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TGFBI expression is associated with a better response to chemotherapy in NSCLC
Marta Irigoyen et al.
MOLECULAR CANCER (2010)
Molecular predictive and prognostic markers in non-small-cell lung cancer
Linda E. Coate et al.
LANCET ONCOLOGY (2009)
Two novel VHL targets, TGFBl (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors
Sergey V. Ivanov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR
Jinesh N. Shah et al.
BMC CANCER (2008)
Predicting survival in potentially curable lung cancer patients
Thida Win et al.
LUNG (2008)
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel
Ahmed Ashour Ahmed et al.
CANCER CELL (2007)
Treatment of non-small cell lung cancer stage I and stage II - ACCP evidence-based clinical practice guidelines (2nd edition)
Walter J. Scott et al.
CHEST (2007)
Treatment of non-small cell lung cancer-stage IIIA - ACCP evidence-based clinical practice guidelines (2nd edition)
Lary A. Robinson et al.
CHEST (2007)
TGFBIp/beta ig-h3 protein: A versatile matrix molecule induced by TGF-beta
Narendra Thapa et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epigenetic inactivation of Betaig-h3 gene in human cancer cells
Genze Shao et al.
CANCER RESEARCH (2006)
Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells
YL Zhao et al.
MOLECULAR CARCINOGENESIS (2006)
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
R Rosell et al.
CLINICAL CANCER RESEARCH (2004)
Down-regulation of Betaig-h3 gene is involved in the tumorigenesis in human bronchial epithelial cells induced by heavy-ion radiation
YL Zhao et al.
RADIATION RESEARCH (2004)
Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3
S Morand et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
RGD peptides released from βig-h3, a TGF-β-induced cell-adhesive molecule, mediate apoptosis
JE Kim et al.
ONCOGENE (2003)
Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells
YL Zhao et al.
ONCOGENE (2002)
Induction and expression of βig-h3 in pancreatic cancer cells
D Schneider et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-β-induced gene, βig-h3
JE Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
